Kengreal 50 MG vials
Ended Awarded
- Contract number
- SPE2DR26F34DM
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,475
Award facts
- Contract value 100% obligated
- $8,474.85 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued an $8,474.85 delivery order to Amerisourcebergen Drug Corp on July 15, 2026, for 50 mg vials of Kengreal (cangrelor), a P2Y12 platelet inhibitor used in acute coronary syndrome management. Place of performance is Conshohocken, PA. Ultimate completion date is July 16, 2026. The order carries a firm fixed price and no set-aside.
Quick answers
Who was awarded contract SPE2DR26F34DM?
SPE2DR26F34DM was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 15, 2026.
How much is contract SPE2DR26F34DM worth?
The government has obligated $8,475 on SPE2DR26F34DM.
Is contract SPE2DR26F34DM an order under another contract?
Yes. SPE2DR26F34DM is a delivery order under SPE2DR25D3301, an indefinite delivery contract.
Was contract SPE2DR26F34DM competed?
The extent of competition for SPE2DR26F34DM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award